"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
| Descriptor ID |
D008113
|
| MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
| Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2018 | 2 | 0 | 2 |
| 2019 | 2 | 1 | 3 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Sublethal necroptosis signaling promotes inflammation and liver cancer. Immunity. 2023 07 11; 56(7):1578-1595.e8.
-
A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma. Hepatol Commun. 2023 07 01; 7(7).
-
Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation. Oncologist. 2022 07 05; 27(7):e561-e570.
-
LINC00152 Drives a Competing Endogenous RNA Network in Human Hepatocellular Carcinoma. Cells. 2022 05 03; 11(9).
-
The RNA binding protein human antigen R is a gatekeeper of liver homeostasis. Hepatology. 2022 04; 75(4):881-897.
-
DNA methylation profile of a hepatosplenic gamma/delta T-cell lymphoma patient associated with response to interferon-a therapy. Cell Mol Immunol. 2021 05; 18(5):1332-1335.
-
Genetic Variants in the Promoter Region of the Macrophage Migration Inhibitory Factor are Associated with the Severity of Hepatitis C Virus-Induced Liver Fibrosis. Int J Mol Sci. 2019 Jul 31; 20(15).
-
Metastasis of pancreatic cancer: An uninflamed liver micromilieu controls cell growth and cancer stem cell properties by oxidative phosphorylation in pancreatic ductal epithelial cells. Cancer Lett. 2019 07 01; 453:95-106.
-
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 2019 01 10; 47(1):375-390.
-
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma. Proc Natl Acad Sci U S A. 2018 09 11; 115(37):9282-9287.
MeSH information
